Get informed when a big investor buys or sells
+ Follow-65.35%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Fermentalg S.A. (FALG.PA) currently reports a ROE of -65.35%. That is below the Healthcare sector average of 9.17%. Use the charts on this page to explore Fermentalg S.A.'s ROE history and peer comparisons.
Fermentalg S.A.'s ROE of -65.35% is lower than the Healthcare sector average of 9.17%. That is roughly 812.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Fermentalg S.A.'s current -65.35% should be judged against Healthcare norms (sector average: 9.17%) and against FALG.PA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -65.35%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.17%. From there, open related valuation or income-statement pages for Fermentalg S.A., and consider following FALG.PA for alerts when major investors trade the stock.
Fermentalg S.A. is classified in the Healthcare sector. On ROE, it currently shows -65.35% versus a sector average near 9.17%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FALG.PA with unrelated industries.